151 related articles for article (PubMed ID: 18974063)
1. COX-2 promoter polymorphisms and the association with prostate cancer risk in South African men.
Fernandez P; de Beer PM; van der Merwe L; Heyns CF
Carcinogenesis; 2008 Dec; 29(12):2347-50. PubMed ID: 18974063
[TBL] [Abstract][Full Text] [Related]
2. COX-2 gene promoter haplotypes and prostate cancer risk.
Panguluri RC; Long LO; Chen W; Wang S; Coulibaly A; Ukoli F; Jackson A; Weinrich S; Ahaghotu C; Isaacs W; Kittles RA
Carcinogenesis; 2004 Jun; 25(6):961-6. PubMed ID: 14754878
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in the COX-2 gene and the association with prostate cancer risk.
Shahedi K; Lindström S; Zheng SL; Wiklund F; Adolfsson J; Sun J; Augustsson-Bälter K; Chang BL; Adami HO; Liu W; Grönberg H; Xu J
Int J Cancer; 2006 Aug; 119(3):668-72. PubMed ID: 16506214
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in COX-2 gene influence prostate cancer susceptibility in a northern Indian cohort.
Mandal RK; Mittal RD
Arch Med Res; 2011 Oct; 42(7):620-6. PubMed ID: 22023987
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 polymorphisms and breast cancer associated risk in Pakistani patients.
Moatter T; Aban M; Iqbal W; Pervez S
Pathol Oncol Res; 2015 Jan; 21(1):97-101. PubMed ID: 24789723
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in regulatory regions of cyclooxygenase-2 gene and breast cancer risk in Brazilians: a case-control study.
Piranda DN; Festa-Vasconcellos JS; Amaral LM; Bergmann A; Vianna-Jorge R
BMC Cancer; 2010 Nov; 10():613. PubMed ID: 21059239
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 gene polymorphisms in an Australian population: association of the -1195G > A promoter polymorphism with mild asthma.
Shi J; Misso NL; Kedda MA; Horn J; Welch MD; Duffy DL; Williams C; Thompson PJ
Clin Exp Allergy; 2008 Jun; 38(6):913-20. PubMed ID: 18489027
[TBL] [Abstract][Full Text] [Related]
8. Linkage disequilibrium and haplotype analysis of COX-2 and risk of colorectal adenoma development.
Kwagyan J; Apprey V; Ashktorab H
Clin Transl Sci; 2012 Feb; 5(1):60-4. PubMed ID: 22376259
[TBL] [Abstract][Full Text] [Related]
9. Association of CD14 variant with prostate cancer in African American men.
Mason TE; Ricks-Santi L; Chen W; Apprey V; Joykutty J; Ahaghotu C; Kittles R; Bonney G; Dunston GM
Prostate; 2010 Feb; 70(3):262-9. PubMed ID: 19830784
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor beta polymorphism is associated with prostate cancer risk.
Thellenberg-Karlsson C; Lindström S; Malmer B; Wiklund F; Augustsson-Bälter K; Adami HO; Stattin P; Nilsson M; Dahlman-Wright K; Gustafsson JA; Grönberg H
Clin Cancer Res; 2006 Mar; 12(6):1936-41. PubMed ID: 16551880
[TBL] [Abstract][Full Text] [Related]
11. Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels.
Cramer SD; Chang BL; Rao A; Hawkins GA; Zheng SL; Wade WN; Cooke RT; Thomas LN; Bleecker ER; Catalona WJ; Sterling DA; Meyers DA; Ohar J; Xu J
J Natl Cancer Inst; 2003 Jul; 95(14):1044-53. PubMed ID: 12865450
[TBL] [Abstract][Full Text] [Related]
12. COX2 genetic variation, NSAIDs, and advanced prostate cancer risk.
Cheng I; Liu X; Plummer SJ; Krumroy LM; Casey G; Witte JS
Br J Cancer; 2007 Aug; 97(4):557-61. PubMed ID: 17609663
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 polymorphisms and risk of rheumatoid arthritis in Koreans.
Yun HR; Lee SO; Choi EJ; Shin HD; Jun JB; Bae SC
J Rheumatol; 2008 May; 35(5):763-9. PubMed ID: 18381795
[TBL] [Abstract][Full Text] [Related]
14. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
[TBL] [Abstract][Full Text] [Related]
15. Common genetic variation in IGF1 and prostate cancer risk in the Multiethnic Cohort.
Cheng I; Stram DO; Penney KL; Pike M; Le Marchand L; Kolonel LN; Hirschhorn J; Altshuler D; Henderson BE; Freedman ML
J Natl Cancer Inst; 2006 Jan; 98(2):123-34. PubMed ID: 16418515
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase 2 genetic polymorphism may increase the risk of developing leukoaraiosis in Chinese.
Shan XY; Chen GZ; Cheng GP; Tao HM
J Mol Neurosci; 2013 Oct; 51(2):461-6. PubMed ID: 23852948
[TBL] [Abstract][Full Text] [Related]
17. Region 2 of 8q24 is associated with the risk of aggressive prostate cancer in Caribbean men of African descent from Guadeloupe (French West Indies).
Cancel-Tassin G; Romana M; Gaffory C; Blanchet P; Cussenot O; Multigner L
Asian J Androl; 2015; 17(1):117-9. PubMed ID: 25130587
[TBL] [Abstract][Full Text] [Related]
18. PTGS2-899G>C and prostate cancer risk: a population-based nested case-control study (ProtecT) and a systematic review with meta-analysis.
Murad A; Lewis SJ; Smith GD; Collin SM; Chen L; Hamdy FC; Neal DE; Donovan J; Martin RM
Prostate Cancer Prostatic Dis; 2009; 12(3):296-300. PubMed ID: 19488068
[TBL] [Abstract][Full Text] [Related]
19. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.
Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411
[TBL] [Abstract][Full Text] [Related]
20. -765 G→C and -1195 A→G promoter variants of the cyclooxygenase-2 gene decrease the risk for preeclampsia.
Gurdol F; Cakmakoglu B; Dasdemir S; Isbilen E; Bekpinar S; Isbir T
Genet Test Mol Biomarkers; 2012 May; 16(5):435-8. PubMed ID: 22224631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
